Enhancement of a STING Agonist Vaccine for Tuberculosis Using Locally Supercharged MS2 Viral Capsids
Hannah S. Martin, Isabel D amb-Echegaray, Paul Huang, Lillian Shallow, Amir Balakhmet, Preeta Pratakshya, Sarah A. Stanley, Matthew B. Francis
This paper develops a vaccine platform using MS2 viral capsids to deliver an Mtb antigen and STING agonist, reducing the required dose and cost while maintaining efficacy.
ACS Central Science · Oct 29, 2026Peer-reviewedImmunology